Author

K. M. Kistner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 1

Frequent Co-Authors

C. Setz· 1 shared G. Andrieux· 1 shared H. Jumaa· 1 shared H. Zhou· 1 shared J. Jellusova· 1 shared J. Maurer· 1 shared J. Strietz· 1 shared K. Raute· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

C. Setz

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivApr 4, 2022

Breast cancer stem cell-derived tumors escape from γδ T cell immunosurveillance in vivo by modulating γδ T cell ligands

K. Raute, J. Strietz, G. Andrieux…·S. Minguet

This study shows that breast cancer stem cells escape γδ T cell immunosurveillance by losing key ligands and antigens, and that this escape can be reversed with Zoledronate or IFN- treatment.

DOI 10.1158/2326-6066.cir-22-0296

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintSep 17, 2021

Accumulation of the GSK3 target protein β-catenin is lethal for B cell precursors and malignant B cells

H. Jumaa, K. M. Kistner, C. Setz…·J. Jellusova

This study shows that β-catenin accumulation caused by GSK3 inhibition leads to reduced survival in B cell precursors and malignant B cells.

DOI 10.1101/2021.09.17.460779

humanexperimental assay

𝕏 PostBluesky